Search results
Added:
4 months ago
Source:
Radcliffe CVRM
While obesity is a known risk factor for premature cardiovascular ageing, the specific impact of body fat distribution has been less clear. A new study analysing data from the UK Biobank suggests that where fat is stored has a significant, and sometimes sex-specific, influence on the biological age of the cardiovascular system.¹This cross-sectional study analysed data from 21,241 participants in…
View more
Hung-Fat Tse
Author
Is Obesity Management Crucial for Ablation Success?
Added:
11 months ago
Review Article
Targeting Obesity for Heart Failure
Added:
3 months ago
Review Article
GLP-1RAs: Mechanism of Action and Role in HFpEF Management
Added:
5 months ago
Review Article
GLP-1RA in Different HFpEF Phenotypes
Added:
1 year ago
Review Article
Effects of GLP-1 Receptor Agonists in Heart Failure Patients
Added:
1 year ago
Review Article
Added:
1 year ago
How should obesity be redefined to establish objective criteria for improved disease diagnosis?In this short interview, Dr Robert Eckel (University of Colorado Anschutz Medical Campus, Aurora, US) discusses the recently published article, "Definition and diagnostic criteria of clinical obesity" based on the Lancet Diabetes and Endocrinology Commission's new consensus redefining obesity. The…
View more
Understanding the Role of GLP-1 RAs in the Treatment of HF
Added:
8 months ago
Review Article
Added:
6 months ago
EASD Congress 2025 - Dr Camilla Andersen (The University of Western Australia, Perth, AU) joins us to discuss findings from the EMPIRE-PREVENT: Metabolic study, investigating the metabolic effects of empagliflozin in elderly and obese patients at high risk of developing heart failure (HF).This randomized controlled trial evaluated 165 patients aged 60–84 years with obesity (BMI >28kg/m²) and…
View more